Research programme: HIV infections - Southern Research InstituteAlternative Names: HIV infections research programme - Southern Research Institute
Latest Information Update: 22 Jan 2003
At a glance
- Originator Nonindustrial source; Southern Research Institute
- Mechanism of Action HIV envelope protein gp120 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 24 Apr 2001 Preclinical development for HIV infections treatment in USA (Unknown route)